Browsing Tag

MNPR

Monopar to Present at Roth Inaugural Healthcare Opportunities Conference

Eli Pacheco Sep 28, 2022 0

WILMETTE, Ill., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics…

Health

Monopar Announces Clinical and Preclinical Program Updates

Eli Pacheco Feb 15, 2022 0

Validive Phase 2b/3 VOICE trial now open at 43 sites; active and enrolling in US and EU Open-label Phase 1b camsirubicin trial: early signs of clinical benefit observed WILMETTE, Ill.,…